Previous studies have reported that CA9, EXTL2, PGAM1, and TYMS were dysregulated across multiple human cancers and intricately associated with tumorigenesis by functioning as key enzymes underlying metabolism (33–36). This evidence concerns the gene PGAM1 and cancer.